ARTICLE | Clinical News
Afstyla regulatory update
January 13, 2017 8:48 PM UTC
The European Commission approved an MAA from CSL for Afstyla lonoctocog alfa for treatment and prophylaxis of bleeding in patients with hemophilia A. CSL plans to launch Afstyla in Europe “in the comi...
BCIQ Company Profiles